Schouten JT and Whittemore S |
Recent development in the treatment and prevention of disseminated Mycobacterium avium complex (MAC). |
1996 |
STEP Perspect |
pmid:11364267
|
Tabbara KF et al. |
Single-dose azithromycin in the treatment of trachoma. A randomized, controlled study. |
1996 |
Ophthalmology |
pmid:8637698
|
Hulten K et al. |
In-vitro activity of azithromycin in against intracellular Helicobacter pylori. |
1996 |
J. Antimicrob. Chemother. |
pmid:9182105
|
Na-Bangchang K et al. |
Activity of artemether-azithromycin versus artemether-doxycycline in the treatment of multiple drug resistant falciparum malaria. |
1996 |
Southeast Asian J. Trop. Med. Public Health |
pmid:9185262
|
Rodriguez AF |
An open study to compare azithromycin with cefaclor in the treatment of children with acute otitis media. |
1996 |
J. Antimicrob. Chemother. |
pmid:8818847
|
O'Doherty B |
An open comparative study of azithromycin versus cefaclor in the treatment of patients with upper respiratory tract infections. |
1996 |
J. Antimicrob. Chemother. |
pmid:8818848
|
Müller O |
An open comparative study of azithromycin and roxithromycin in the treatment of acute upper respiratory tract infections. |
1996 |
J. Antimicrob. Chemother. |
pmid:8818849
|
Gris P |
Once-daily, 3-day azithromycin versus a three-times-daily, 10-day course of co-amoxiclav in the treatment of adults with lower respiratory tract infections: results of a randomized, double-blind comparative study. |
1996 |
J. Antimicrob. Chemother. |
pmid:8818850
|
Zachariah J |
A randomized, comparative study to evaluate the efficacy and tolerability of a 3-day course of azithromycin versus a 10-day course of co-amoxiclav as treatment of adult patients with lower respiratory tract infections. |
1996 |
J. Antimicrob. Chemother. |
pmid:8818851
|
Laurent K |
Efficacy, safety and tolerability of azithromycin versus roxithromycin in the treatment of acute lower respiratory tract infections. |
1996 |
J. Antimicrob. Chemother. |
pmid:8818852
|
Montero L |
A comparative study of the efficacy, safety and tolerability of azithromycin and cefaclor in the treatment of children with acute skin and/or soft tissue infections. |
1996 |
J. Antimicrob. Chemother. |
pmid:8818853
|
Nahata M |
Drug interactions with azithromycin and the macrolides: an overview. |
1996 |
J. Antimicrob. Chemother. |
pmid:8818854
|
Treadway G and Pontani D |
Paediatric safety of azithromycin: worldwide experience. |
1996 |
J. Antimicrob. Chemother. |
pmid:8818855
|
Carbon C et al. |
Economic analysis of antibiotic regimens used in the treatment pharyngitis: a prospective comparison of azithromycin versus roxithromycin. |
1996 |
J. Antimicrob. Chemother. |
pmid:8818856
|
Worth S et al. |
Quality control guidelines for amoxicillin, amoxicillin-clavulanate, azithromycin, piperacillin-tazobactam, roxithromycin, ticarcillin, ticarcillin-clavulanate, trovafloxacin (CP 99,219), U-100592, and U-100766 for various National Committee for Clinical Laboratory Standards susceptibility testing methods. Results from multicenter trials. |
1996 |
Diagn. Microbiol. Infect. Dis. |
pmid:9147914
|
Gerbaux C et al. |
Hyperactivity of cathepsin B and other lysosomal enzymes in fibroblasts exposed to azithromycin, a dicationic macrolide antibiotic with exceptional tissue accumulation. |
1996 |
FEBS Lett. |
pmid:8830663
|
Hultén K et al. |
New pharmacokinetic in vitro model for studies of antibiotic activity against intracellular microorganisms. |
1996 |
Antimicrob. Agents Chemother. |
pmid:9124830
|
Domingo S and Gamazo C |
Inadequate azithromycin activity against Brucella melitensis in mice with acute or chronic infections. |
1996 |
J Chemother |
pmid:8835110
|
Marchisio P et al. |
Comparative study of once-weekly azithromycin and once-daily amoxicillin treatments in prevention of recurrent acute otitis media in children. |
1996 |
Antimicrob. Agents Chemother. |
pmid:9124831
|
Conte JE et al. |
Single-dose intrapulmonary pharmacokinetics of azithromycin, clarithromycin, ciprofloxacin, and cefuroxime in volunteer subjects. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8807050
|
Nash KA and Inderlied CB |
Rapid detection of mutations associated with macrolide resistance in Mycobacterium avium complex. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8807078
|
Meloni G and Meloni T |
Azithromycin vs. doxycycline for Mediterranean spotted fever. |
1996 |
Pediatr. Infect. Dis. J. |
pmid:8933556
|
Jackson MA et al. |
Breakthrough sepsis in macrolide-resistant pneumococcal infection. |
1996 |
Pediatr. Infect. Dis. J. |
pmid:8933560
|
Ballard RC et al. |
Treatment of chancroid with azithromycin. |
1996 |
Int J STD AIDS |
pmid:8652728
|
Bowden FJ et al. |
Pilot study of azithromycin in the treatment of genital donovanosis. |
1996 |
Genitourin Med |
pmid:8655160
|
Kohl PK et al. |
Gonorrhoea: single-dose oral treatment. |
1996 |
Curr. Probl. Dermatol. |
pmid:8743257
|
Nickel P and Näher H |
Nongonococcal urethritis. |
1996 |
Curr. Probl. Dermatol. |
pmid:8743259
|
Johnson RB |
Azithromycin. |
1996 |
Curr. Probl. Dermatol. |
pmid:8743269
|
Caselli M et al. |
A comparative trial of short term therapy with omeprazole plus either amoxycillin or azithromycin for Helicobacter pylori eradication. |
1996 |
J. Antimicrob. Chemother. |
pmid:8722557
|
MashkilleÄson AL |
[The treatment of early syphilis today]. |
1996 |
Ter. Arkh. |
pmid:9045378
|
Falagas ME and Klempner MS |
Babesiosis in patients with AIDS: a chronic infection presenting as fever of unknown origin. |
1996 |
Clin. Infect. Dis. |
pmid:8722936
|
Murphy GS et al. |
Ciprofloxacin- and azithromycin-resistant Campylobacter causing traveler's diarrhea in U.S. troops deployed to Thailand in 1994. |
1996 |
Clin. Infect. Dis. |
pmid:8722958
|
Luke DR et al. |
Safety, toleration, and pharmacokinetics of intravenous azithromycin. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8913468
|
Scorneaux B et al. |
Effect of recombinant human gamma interferon on intracellular activities of antibiotics against Listeria monocytogenes in the human macrophage cell line THP-1. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8723471
|
Olsen KM et al. |
Intrapulmonary pharmacokinetics of azithromycin in healthy volunteers given five oral doses. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8913469
|
Havlir DV et al. |
Prophylaxis against disseminated Mycobacterium avium complex with weekly azithromycin, daily rifabutin, or both. California Collaborative Treatment Group. |
1996 |
N. Engl. J. Med. |
pmid:8676932
|
Kuo CC et al. |
In vitro activities of azithromycin, clarithromycin, and other antibiotics against Chlamydia pneumoniae. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8913488
|
Tursi A et al. |
The use of azithromycin in short-term low-dose triple therapies for Helicobacter pylori infection. |
1996 |
Am. J. Gastroenterol. |
pmid:8677967
|
Aoyama T et al. |
Efficacy of short-term treatment of pertussis with clarithromycin and azithromycin. |
1996 |
J. Pediatr. |
pmid:8917247
|
Thorpe EM et al. |
Chlamydial cervicitis and urethritis: single dose treatment compared with doxycycline for seven days in community based practises. |
1996 |
Genitourin Med |
pmid:8698374
|
Pacifico L et al. |
Comparative efficacy and safety of 3-day azithromycin and 10-day penicillin V treatment of group A beta-hemolytic streptococcal pharyngitis in children. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8849215
|
Wilton LV et al. |
A comparison of ciprofloxacin, norfloxacin, ofloxacin, azithromycin and cefixime examined by observational cohort studies. |
1996 |
Br J Clin Pharmacol |
pmid:8730972
|
Jaruratanasirikul S et al. |
Distribution of azithromycin into brain tissue, cerebrospinal fluid, and aqueous humor of the eye. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8851625
|
Bedos JP and Veber B |
[Lower respiratory infections: predictive factors of therapeutic response]. |
1996 |
Rev Pneumol Clin |
pmid:9033917
|
Zuck P |
[Efficacy of a 5-day treatment with an azalide (azithromycin) in superinfections of chronic bronchitis]. |
1996 |
Rev Pneumol Clin |
pmid:9033919
|
Hayle R et al. |
Efficacy and safety of azithromycin versus phenoxymethylpenicillin in the treatment of acute maxillary sinusitis. |
1996 |
Eur. J. Clin. Microbiol. Infect. Dis. |
pmid:8997555
|
Magid D et al. |
Doxycycline compared with azithromycin for treating women with genital Chlamydia trachomatis infections: an incremental cost-effectiveness analysis. |
1996 |
Ann. Intern. Med. |
pmid:8554247
|
Schwartz RA et al. |
Bacillary angiomatosis in an HIV seronegative patient on systemic steroid therapy. |
1996 |
Br. J. Dermatol. |
pmid:8977724
|
Genç M and Mårdh A |
A cost-effectiveness analysis of screening and treatment for Chlamydia trachomatis infection in asymptomatic women. |
1996 |
Ann. Intern. Med. |
pmid:7503471
|
McCarty J |
A multicenter, open label trial of azithromycin for the treatment of children with acute otitis media. |
1996 |
Pediatr. Infect. Dis. J. |
pmid:8878240
|
Aronovitz G |
A multicenter, open label trial of azithromycin vs. amoxicillin/ clavulanate for the management of acute otitis media in children. |
1996 |
Pediatr. Infect. Dis. J. |
pmid:8878241
|
McLinn S |
A multicenter, double blind comparison of azithromycin and amoxicillin/ clavulanate for the treatment of acute otitis media in children. |
1996 |
Pediatr. Infect. Dis. J. |
pmid:8878242
|
Khurana CM |
A multicenter, randomized, open label comparison of azithromycin and amoxicillin/clavulanate in acute otitis media among children attending day care or school. |
1996 |
Pediatr. Infect. Dis. J. |
pmid:8878243
|
Powers JL |
Properties of azithromycin that enhance the potential for compliance in children with upper respiratory tract infections. |
1996 |
Pediatr. Infect. Dis. J. |
pmid:8878244
|
Wenisch C et al. |
Effect of single oral dose of azithromycin, clarithromycin, and roxithromycin on polymorphonuclear leukocyte function assessed ex vivo by flow cytometry. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8878577
|
Yeates RA et al. |
Interaction between midazolam and clarithromycin: comparison with azithromycin. |
1996 |
Int J Clin Pharmacol Ther |
pmid:8880291
|
Dunn CJ and Barradell LB |
Azithromycin. A review of its pharmacological properties and use as 3-day therapy in respiratory tract infections. |
1996 |
Drugs |
pmid:8882383
|
Gnarpe J et al. |
In vitro activities of azithromycin and doxycycline against 15 isolates of Chlamydia pneumoniae. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8843291
|
Keysary A et al. |
The in-vitro anti-rickettsial activity of macrolides. |
1996 |
J. Antimicrob. Chemother. |
pmid:8937968
|
Mein J et al. |
Donovanosis: sequelae of severe disease and successful azithromycin treatment. |
1996 |
Int J STD AIDS |
pmid:8940677
|
Hoque S et al. |
Rhodococcus equi in CAPD-associated peritonitis treated with azithromycin. |
1996 |
Nephrol. Dial. Transplant. |
pmid:8941608
|
Wiselka MJ et al. |
Response to oral and intravenous azithromycin in a patient with toxoplasma encephalitis and AIDS. |
1996 |
J. Infect. |
pmid:8945715
|
Gómez E et al. |
Interaction between azithromycin and cyclosporin? |
1996 |
Nephron |
pmid:8856287
|
Delmée M et al. |
In vitro susceptibilities of 180 clinical isolates of Haemophilus influenzae to ampicillin, amoxycillin/clavulanate, cefaclor, cefuroxime, cefotaxime, clarithromycin, and azithromycin. |
1996 |
Acta Clin Belg |
pmid:8858889
|
Mashkilleyson AL et al. |
Treatment of syphilis with azithromycin. |
1996 |
Int J STD AIDS |
pmid:8652720
|
Amsden GW |
Erythromycin, clarithromycin, and azithromycin: are the differences real? |
1996 Jan-Feb |
Clin Ther |
pmid:8851453
|
Preac Mursic V et al. |
Kill kinetics of Borrelia burgdorferi and bacterial findings in relation to the treatment of Lyme borreliosis. |
1996 Jan-Feb |
Infection |
pmid:8852456
|
Baradaran-Dilmaghani R and Stanek G |
In vitro susceptibility of thirty Borrelia strains from various sources against eight antimicrobial chemotherapeutics. |
1996 Jan-Feb |
Infection |
pmid:8852472
|
Strle F et al. |
Azithromycin and doxycycline for treatment of Borrelia culture-positive erythema migrans. |
1996 Jan-Feb |
Infection |
pmid:8852473
|
Fontán PA et al. |
Haemophilus influenzae type b exoproducts induce chemotaxis and macrolide antibiotic release by human polymorphonuclear leukocytes. |
1996 Jan-Feb |
Chemotherapy |
pmid:8751269
|
Ehret JM et al. |
A clinical isolate of Neisseria gonorrhoeae with in vitro resistance to erythromycin and decreased susceptibility to azithromycin. |
1996 Jul-Aug |
Sex Transm Dis |
pmid:8836018
|
Lane G |
Increased hypoprothrombinemic effect of warfarin possibly induced by azithromycin. |
1996 Jul-Aug |
Ann Pharmacother |
pmid:8826581
|
Diculencu D et al. |
[The postantibiotic effect of azithromycin on respiratory pathogens]. |
1996 Jul-Dec |
Rev Med Chir Soc Med Nat Iasi |
pmid:9455450
|
Carlin EM and Barton SE |
Azithromycin as the first-line treatment of non-gonococcal urethritis (NGU): a study of follow-up rates, contact attendance and patients' treatment preference. |
1996 May-Jun |
Int J STD AIDS |
pmid:8799780
|
Shanks GD et al. |
Azithromycin prophylaxis prevents epidemic dysentery. |
1996 May-Jun |
Trans. R. Soc. Trop. Med. Hyg. |
pmid:8758091
|
Adam D et al. |
Re: A. Bauernfeind et al.: Comparative pharmacodynamics of clarithromycin and azithromycin against respiratory pathogens (Infection 23 [1995] 316-321) |
1996 May-Jun |
Infection |
pmid:8811372
|
Vranes J |
Effect of subinhibitory concentrations of ceftazidime, ciprofloxacin, and azithromycin on the hemagglutination and adherence of uropathogenic Escherichia coli strains. |
1996 May-Jun |
Chemotherapy |
pmid:8983884
|
Ichimiya T et al. |
The influence of azithromycin on the biofilm formation of Pseudomonas aeruginosa in vitro. |
1996 May-Jun |
Chemotherapy |
pmid:8983885
|
Galova K et al. |
Multicenter randomized study of two once daily regimens in the initial management of community-acquired respiratory tract infections in 163 children: azithromycin versus ceftibuten. |
1996 May-Jun |
Chemotherapy |
pmid:8983893
|
Burke SM |
Azithromycin: only once a day. |
1996 May-Jun |
MCN Am J Matern Child Nurs |
pmid:8857402
|
Ripa S et al. |
A linear model for the pharmacokinetics of azithromycin in healthy volunteers. |
1996 Nov-Dec |
Chemotherapy |
pmid:8957574
|
D'Amico R |
ICAAC update on opportunistic infections. |
1996 Nov-Dec |
Posit Aware |
pmid:11363974
|
Wendel TD |
1-day azithromycin was as effective as 7-day doxycycline for nongonococcal urethritis syndrome in men. |
1996 Nov-Dec |
ACP J. Club |
pmid:8912627
|
Peeling RW and Brunham RC |
Chlamydiae as pathogens: new species and new issues. |
1996 Oct-Dec |
Emerging Infect. Dis. |
pmid:8969247
|
Biebuyck XA |
Comparison of azithromycin and co-amoxiclav in the treatment of acute tracheobronchitis and acute infectious exacerbations of chronic bronchitis in adults. Azithromycin Study Group. |
1996 Sep-Oct |
J. Int. Med. Res. |
pmid:8895044
|
Ramos JT et al. |
Cryptosporidium in patients infected with human immunodeficiency virus: azithromycin revisited. |
1997 |
J. Pediatr. |
pmid:9202631
|
Nachbaur D et al. |
Cryptosporidiosis after CD34-selected autologous peripheral blood stem cell transplantation (PBSCT). Treatment with paromomycin, azithromycin and recombinant human interleukin-2. |
1997 |
Bone Marrow Transplant. |
pmid:9208124
|
Luke DR and Foulds G |
Disposition of oral azithromycin in humans. |
1997 |
Clin. Pharmacol. Ther. |
pmid:9209246
|
Herrera-Insúa I et al. |
Synergistic effect of azithromycin on the phagocytic killing of Staphylococcus aureus by human polymorphonuclear leukocytes. |
1997 |
Eur. J. Clin. Microbiol. Infect. Dis. |
pmid:9063667
|
Rouse MS et al. |
Efficacy of azithromycin or clarithromycin for prophylaxis of viridans group streptococcus experimental endocarditis. |
1997 |
Antimicrob. Agents Chemother. |
pmid:9257739
|
Carlin EM and Barton SE |
Azithromycin as a cost-effective treatment for nongonococcal urethritis in men. |
1997 |
Sex Transm Dis |
pmid:9018784
|
Mosby JA |
Treating acute bronchitis with azithromycin. |
1997 |
Am Fam Physician |
pmid:9054218
|
Visalli MA et al. |
Susceptibility of twenty penicillin-susceptible and -resistant pneumococci to levofloxacin, ciprofloxacin, ofloxacin, erythromycin, azithromycin, and clarithromycin by MIC and time-kill. |
1997 |
Diagn. Microbiol. Infect. Dis. |
pmid:9294703
|
Visalli MA et al. |
Susceptibility of penicillin-susceptible and -resistant pneumococci to dirithromycin compared with susceptibilities to erythromycin, azithromycin, clarithromycin, roxithromycin, and clindamycin. |
1997 |
Antimicrob. Agents Chemother. |
pmid:9303375
|
Dudle G et al. |
[Meningitis after acute Borrelia burgdorferi infection in HIV infection]. |
1997 |
Dtsch. Med. Wochenschr. |
pmid:9378035
|
Dautzenberg B |
Rationale for the prevention of disseminated Mycobacterium avium-intracellulare complex disease. |
1997 |
Drugs |
pmid:9358194
|
Handsfield HH |
Azithromycin in gonorrhoea. |
1997 |
Int J STD AIDS |
pmid:9228599
|
Cohn DL |
Prevention strategies for Mycobacterium avium-intracellulare complex (MAC) infection. A review of recent studies in patients with AIDS. |
1997 |
Drugs |
pmid:9358195
|
Nyström-Rosander C et al. |
Susceptibility of Chlamydia pneumoniae to azithromycin and doxycycline: methodological aspects on the determination of minimal inhibitory and minimal bactericidal concentrations. |
1997 |
Scand. J. Infect. Dis. |
pmid:9435043
|
Barry AL et al. |
In vitro activity of the new ketolide HMR 3004 compared to an azalide and macrolides against Streptococcus pneumoniae and Haemophilus influenzae. |
1997 |
Eur. J. Clin. Microbiol. Infect. Dis. |
pmid:9405952
|